top of page
Who are we
Built by the scientists who redefined RNA delivery —
and are now redefining cancer therapy.
Our Mission
To pioneer safe, scalable, and powerful immunotherapies that harness the body’s full immune potential against cancer.
Our Vision
Empowering global health utilizing Synthetic Biology with a universal RNA-Lipid Nanoparticle (LNP) platform for cancer immunotherapies.
Our Edge
World-class expertise in Synthetic Biology and Lipid Nanoparticles with a next-gen modular platform mimicking natural viral infections without the risks.
Built from two world-leading labs, ViVac pioneers biotechnology by uniting synthetic biology and lipid nanoparticle science to develop RNA-based immunotherapies that safely eliminate cancer from within.
Our team unites world-class scientists, entrepreneurs, and industry leaders dedicated to one mission:
To reprogram the immune system’s language — and give it the power to outsmart cancer.
Leadership Team
Leadership Team
ViVac is led by a world-class team of pioneers in synthetic biology, nanomedicine, and biotech innovation — united by a shared mission to transform how cancer is treated.
Who are we
What began as a viral vaccine revolution is now rewriting the future of cancer therapy.
Renowned Life Science Investors
Testimonials
bottom of page